Sunday, September 13, 2026

Cocoa Futures Jumps By 4% In The Last 10 Sessions

Cocoa Futures Jumps By 4% In The Last 10 Sessions

(VIANEWS) - Cocoa (CC) has been up by 4.37% for the last 10 sessions. At 05:51 EST on Wednesday, 26 July, Cocoa (CC) is $3,486.00.

Volume

Today's last reported volume for Cocoa is 1921, 99.98% below its average volume of 12972846.42.

Volatility

Cocoa's last week, last month's, and last quarter's current intraday variation average was a negative 0.11%, a positive 1.39%, and a positive 2.64%, respectively.

Cocoa's highest amplitude of average volatility was 0.62% (last week), 1.67% (last month), and 2.64% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Cocoa's commodity is considered to be oversold (<=20).

News about

  • Crude oil forecast: markets poised for potential upside - 25 July 2023. According to DailyForex on Tuesday, 25 July, "On Monday, the West Texas Intermediate Crude Oil market showcased an impressive rally, propelling prices closer to the crucial 200-Day EMA. "

More news about Cocoa (CC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com